Eric Trump joins $1.5B bet on US-made AI defense drones

Silexion Therapeutics is developing a potential “holy grail” play in precision oncology (NASDAQ: SLXN) By FinanceWire

NYSE Content Update: USA TODAY Co. Rings Opening Bell to Celebrate Rebrand

Stock market today: Dow, S&P 500, Nasdaq futures slide ahead of shortened week with AI disruption fears in focus

SQQQ Profits When Tech Drops, But the Math Gets Ugly After a Few Days

The Year's Five Best Stocks Already Have A Lot Of Memories